Company intelligence / Profile preview
KDBON
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
KDBON is a South Korean biotechnology company specializing in the development of innovative therapeutics for bone and joint diseases. The company focuses on bone-targeting drug delivery systems and regenerative medicine to treat conditions such as osteoporosis and periodontal disease. Their research leverages small molecules and peptides designed to promote bone formation and inhibit bone resorption. KDBON aims to address unmet medical needs in the aging population by providing more effective and safer treatments for skeletal disorders.
- Therapeutic areas
- EndocrinologyRheumatologyOther
- Modalities
- Small moleculePeptides
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on KDBON.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KDBON.